| Literature DB >> 35234658 |
Max James Western1, Martyn Standage1, Oliver James Peacock1, Tom Nightingale2, Dylan Thompson1.
Abstract
BACKGROUND: Increasing physical activity (PA) behavior remains a public health priority, and wearable technology is increasingly being used to support behavior change efforts. Using wearables to capture and provide comprehensive, visually persuasive, multidimensional feedback with real-time support may be a promising way of increasing PA in inactive individuals.Entities:
Keywords: behavior change; feedback; physical activity; sedentary time; wearables
Year: 2022 PMID: 35234658 PMCID: PMC8928046 DOI: 10.2196/26525
Source DB: PubMed Journal: JMIR Form Res ISSN: 2561-326X
Figure 1Features and examples of feedback and functions included on the Multidimensional Individualized Physical Activity web-based platform. (A) Participants were provided feedback using a traffic light–colored health target attainment schematic across the five dimensions and (B) detailed activity patterns and time use summaries colored in accordance with the intensity of activity during each given minute. (C) Participants were also able to review specific segments of a day to learn about the energy cost and intensity of particular activities and (D) were provided with a planning section where they could see how the addition of new activities, derived from the Ainsworth compendium [33], would affect their health targets if imposed over their existing week.
Figure 2CONSORT (Consolidated Standards of Reporting Trials) flow diagram demonstrating participants’ progress through the study.
Baseline characteristics of study participants (N=51).
| Characteristic | All | Intervention (n=36) | Control (n=15) | |
| Age (years), mean (SD) | 51.3 (8.4) | 52.3 (8.2) | 50.1 (8.3) | |
|
| ||||
|
| 40-55 | 33 (65) | 23 (64) | 10 (67) |
|
| 55-70 | 18 (35) | 13 (36) | 5 (33) |
| Female | 28 (55) | 20 (55) | 8 (53) | |
| Ethnicity (White British) | 46 (90) | 32 (88) | 14 (93) | |
|
| ||||
|
| Married or cohabiting | 42 (82) | 30 (83) | 12 (80) |
|
| Single, divorced, or widowed | 9 (18) | 6 (17) | 3 (20) |
|
| ||||
|
| GCSEa | 3 (6) | 3 (8) | 0 (0) |
|
| A-level | 4 (8) | 3 (8) | 1 (7) |
|
| First degree | 24 (47) | 17 (47) | 7 (47) |
|
| Higher degree | 20 (39) | 13 (36) | 7 (47) |
| Index of Multiple Deprivationb (decile), mean (SD) | 8.0 (2.4) | 7.9 (2.3) | 8.2 (2.6) | |
|
| ||||
|
| 1-5 | 11 (22) | 8 (23) | 3 (20) |
|
| 6-10 | 39 (78) | 27 (77) | 12 (80) |
| Smoker | 2 (4) | 0 (0) | 2 (13) | |
aGCSE: General Certificate of Secondary Education.
bIndex of Multiple Deprivation based on postcode calculated [35].
Mean scores, adjusted mean difference between intervention and control groups, and effect sizes (with 95% CIs) across physical activity dimensions at 6 and 12 weeks.
| Outcome and time point | Intervention (n=36)a, mean (95% CI) | Control (n=15)a, mean (95% CI) | Adjusted mean differencea,b (95% CI) | Effect size, Hedges | |||||
|
| |||||||||
|
| Baseline | 1.61 (1.55 to 1.66) | 1.62 (1.55 to 1.68) | N/Ag | N/A | ||||
|
| Week 6 | 1.62 (1.57 to 1.67) | 1.65 (1.58 to 1.72) | −0.02 (−0.10 to 0.04) | −0.2 (−0.8 to 0.4) | ||||
|
| Week 12 | 1.67 (1.63 to 1.72) | 1.58 (1.52 to 1.64) | 0.09 (0.02 to 0.15) | 0.8 (0.2 to 1.4) | ||||
|
| |||||||||
|
| Baseline | 69 (66 to 73) | 69 (64 to 73) | N/A | N/A | ||||
|
| Week 6 | 69 (66 to 72) | 66 (62 to 70) | 3 (−2 to 8) | 0.3 (−3 to 0.9) | ||||
|
| Week 12 | 66 (63 to 69) | 70 (65 to 74) | −4 (−8 to 1) | −0.5 (–1.1 to 0.1) | ||||
|
| |||||||||
|
| Baseline | 111 (94 to 129) | 117 (99 to 135) | N/A | N/A | ||||
|
| Week 6 | 118 (105 to 130) | 127 (107 to 148) | −10 (−28 to 8) | −0.3 (−0.9 to 0.3) | ||||
|
| Week 12 | 132 (118 to 147) | 109 (89 to 131) | 24 (0 to 45) | 0.6 (0.0 to 1.2) | ||||
|
| |||||||||
|
| Baseline | 42 (23 to 65) | 26 (12 to 43) | N/A | N/A | ||||
|
| Week 6 | 48 (30 to 70) | 46 (24 to 71) | 2 (−24 to 28) | 0.0 (−0.6 to 0.6) | ||||
|
| Week 12 | 50 (30 to 73) | 33 (14 to 55) | 18 (−5 to 41) | 0.4 (−0.2 to 1.0) | ||||
|
| |||||||||
|
| Baseline | 539 (435 to 646) | 509 (400 to 622) | N/A | N/A | ||||
|
| Week 6 | 584 (495 to 675) | 580 (441 to 725) | 4 (−126 to 136) | 0.0 (−0.6 to 0.6) | ||||
|
| Week 12 | 658 (571 to 750) | 462 (340 to 587) | 195 (58 to 331) | 0.8 (0.2 to 1.4) | ||||
|
| |||||||||
|
| Baseline | 7403 (6705 to 8093) | 7767 (6626 to 8884) | N/A | N/A | ||||
|
| Week 6 | 8207 (7269 to 9114) | 8280 (7268 to 9114) | −73 (−1122 to 1017) | 0.0 (−0.6 to 0.6) | ||||
|
| Week 12 | 8782 (7987 to 9656) | 7236 (6496 to 7991) | 1545 (581 to 2553) | 0.7 (0.1 to 1.3) | ||||
aCIs were verified using a bias-corrected and accelerated bootstrap with 5000 replications.
bCovariates included stratified randomization factors (BMI at baseline and sex) and baseline scores for the respective outcome variables.
cPAL: physical activity level.
dMean total daily energy expenditure divided by daily resting metabolic rate.
eTEE: total energy expenditure.
fRMR: resting metabolic rate.
gN/A: not applicable.
hPercentage of waking day.
iAll minutes ≥3 metabolic equivalents of task.
jActivity ≥6 metabolic equivalents of task (vigorous) or ≥3 metabolic equivalents of task (MVPA) accumulated in ≥10 minutes was counted.
kMVPA: moderate to vigorous physical activity.
lMean daily step count.
Secondary health and psychosocial outcomes at 6 and 12 weeks (N=51)a.
| Outcome and week | Baseline, mean (SD) | Intervention, mean (95% CIb) | Control, mean (95% CIb) | Adjusted mean difference (95% CIb) | Effect size (Hedges | |||||||
|
| ||||||||||||
|
|
| |||||||||||
|
|
| 6 weeks | 124 (14) | 123 (118 to 128) | 123 (118 to 128) | 0.2 (–4.69 to 4.86) | 0.02 | |||||
|
|
| 12 weeks | 124 (14) | 124 (120 to 127) | 120 (113 to 127) | 4.33 (–3.33 to 11.43) | 0.43 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 86 (10) | 86 (83 to 90) | 88 (83 to 93) | −1.53 (–6.03 to 3.21) | −0.20 | |||||
|
|
| 12 weeks | 86 (10) | 88 (85 to 91) | 86 (81 to 91) | 1.85 (–3.88 to 7.79) | 0.21 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 81.9 (14.4) | 81.6 (77.8 to 85.4) | 82.3 (78.6 to 86.1) | −0.74 (–1.86 to 0.49) | −0.44 | |||||
|
|
| 12 weeks | 81.9 (14.4) | 81.8 (78.2 to 85.4) | 82.6 (79 to 86.4) | −0.81 (−2 to 0.36) | −0.33 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 91.8 (11.9) | 89.9 (86.6 to 93.3) | 90.8 (87.3 to 94.4) | −0.93 (–2.47 to 0.81) | −0.32 | |||||
|
|
| 12 weeks | 91.8 (11.9) | 89.2 (86.1 to 92.4) | 89.2 (85.7 to 92.9) | 0.01 (–1.67 to 1.77) | 0.00 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 5.3 (0.7) | 5.3 (5.1 to 5.5) | 5.4 (5.2 to 5.6) | −0.08 (−0.32 to 0.17) | −0.22 | |||||
|
|
| 12 weeks | 5.3 (0.7) | 5.3 (5.1,5.5) | 5.5 (5.3 to 5.7) | −0.15 (−0.43 to 0.13) | −0.36 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 6.7 (3.8) | 6.4 (5.2 to 7.7) | 6.6 (5.3 to 8) | −0.18 (–1.85 to 1.7) | −0.06 | |||||
|
|
| 12 weeks | 6.7 (3.8) | 6.1 (5.1 to 7.3) | 7.3 (6 to 8.9) | −1.25 (−2.4 to −0.16) | −0.50 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 1.6 (1.1) | 1.5 (1.2 to 1.9) | 1.6 (1.3 to 2.0) | –0.07 (−0.48 to 0.34) | −0.09 | |||||
|
|
| 12 weeks | 1.6 (1.1) | 1.5 (1.2 to 1.7) | 1.8 (1.5 to 2.1) | −0.34 (−0.61 to −0.62) | −1.23 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 5.6 (0.8) | 5.3 (5 to 5.6) | 5.5 (5.1 to 5.9) | −0.16 (−0.56 to 0.22) | −0.23 | |||||
|
|
| 12 weeks | 5.6 (0.8) | 5.4 (5.2 to 5.6) | 5.5 (5.1 to 6) | −0.14 (−0.65 to 0.32) | −0.23 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 1.3 (0.4) | 1.4 (1.2 to 1.5) | 1.4 (1.3 to 1.5) | −0.04 (−0.17 to 0.11) | −0.18 | |||||
|
|
| 12 weeks | 1.3 (0.4) | 1.4 (1.2 to 1.5) | 1.4 (1.3 to 1.6) | −0.06 (−0.17 to 0.04) | −0.38 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 3.7 (0.8) | 3.5 (3.2 to 3.7) | 3.5 (3.2 to 3.8) | −0.07 (−0.38 to 0.25) | −0.11 | |||||
|
|
| 12 weeks | 3.7 (0.8) | 3.5 (3.3 to 3.7) | 3.5 (3.1 to 3.9) | 0.01 (−0.39 to 0.36) | 0.03 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 1.4 (0.8) | 1.2 (1 to 1.4) | 1.3 (1.1 to 1.6) | −0.12 (−0.39 to 0.14) | −0.27 | |||||
|
|
| 12 weeks | 1.4 (0.8) | 1.2 (1.1 to 1.4) | 1.5 (1.2 to 1.7) | −0.23 (−0.55 to 0.08) | −0.54 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 2.0 (2.6) | 2.4 (1.5 to 3.5) | 1.6 (0.9 to 2.2) | 0.89 (1.11 to 0.18) | 0.32 | |||||
|
|
| 12 weeks | 2.0 (2.6) | 1.9 (1.3 to 2.7) | 3 (1.6 to 4.5) | −1.09 (–2.8 to 0.51) | −0.48 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 65.2 (16.3) | 72.2 (66.8 to 77.3) | 71.7 (63.4 to 79.6) | 0.45 (–7.57 to 8.45) | 0.03 | |||||
|
|
| 12 weeks | 65.2 (16.3) | 69.5 (62.5 to 75.7) | 71.7 (66.6 to 76.7) | −2.12 (–11.23 to 6.47) | −0.12 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 0.90 (0.1) | 0.92 (0.89 to 0.95) | 0.89 (0.85 to 0.93) | 0.03 (−0.01 to 0.07) | 0.38 | |||||
|
|
| 12 weeks | 0.90 (0.1) | 0.89 (0.85 to 0.92) | 0.9 (0.85 to 0.95) | −0.01 (−0.06 to 0.04) | −0.16 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 47.4 (8.4) | 51.1 (48.3 to 53.9) | 48.5 (45.2 to 51.5) | 2.52 (–1.63 to 7.17) | 0.39 | |||||
|
|
| 12 weeks | 47.4 (8.4) | 47.5 (43.8 to 51.1) | 50.1 (46.3 to 53.5) | −2.6 (–7.58 to 2.79) | −0.28 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 49.0 (9.8) | 50.8 (48.4 to 53) | 48.9 (45.3 to 52.6) | 1.86 (–2.29 to 6.03) | 0.26 | |||||
|
|
| 12 weeks | 49.0 (9.8) | 51.7 (47 to 56.3) | 43.8 (38 to 49.4) | 7.93 (0.74 to 15.18) | 0.60 | |||||
|
| ||||||||||||
|
|
| |||||||||||
|
|
| 6 weeks | 2.9 (0.7) | 3.1 (3 to 3.3) | 2.9 (2.7 to 3) | 0.26 (0.04 to 0.49) | 0.79 | |||||
|
|
| 12 weeks | 2.9 (0.7) | 3.1 (2.9 to 3.3) | 3 (2.8 to 3.2) | 0.1 (−0.1 to 0.3) | 0.30 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 1.5 (0.7) | 1.4 (1.2 to 1.6) | 1.7 (1.4 to 1.9) | −0.28 (−0.55 to −0.01) | −0.63 | |||||
|
|
| 12 weeks | 1.5 (0.7) | 1.3 (1.2 to 1.5) | 1.6 (1.3 to 1.8) | −0.2 (−0.5 to 0.09) | −0.42 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 4.7 (1.0) | 4.6 (4.2 to 4.9) | 4.6 (4.3 to 5) | −0.03 (−0.57 to 0.39) | −0.03 | |||||
|
|
| 12 weeks | 4.7 (1.0) | 4.7 (4.5 to 4.9) | 4.6 (4.2 to 4.9) | 0.12 (−0.21 to 0.43) | 0.16 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 5.4 (0.6) | 5.3 (5.1 to 5.5) | 5.4 (5.1 to 5.7) | −0.07 (−0.39 to 0.26) | −0.12 | |||||
|
|
| 12 weeks | 5.4 (0.6) | 5.5 (5.3 to 5.7) | 5.6 (5.4 to 5.7) | −0.09 (−0.32 to 0.16) | −0.17 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 4.1 (1.2) | 4.5 (4.2 to 4.7) | 4.1 (3.7 to 4.5) | 0.36 (−0.1 to 0.77) | 0.47 | |||||
|
|
| 12 weeks | 4.1 (1.2) | 4.3 (3.9 to 4.6) | 4 (3.5 to 4.4) | 0.32 (−0.18 to 0.8) | 0.36 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 4.3 (1.3) | 4.2 (3.7 to 4.6) | 4.5 (4.1 to 4.9) | −0.35 (−0.88 to 0.16) | −0.37 | |||||
|
|
| 12 weeks | 4.3 (1.3) | 4.4 (3.9 to 4.8) | 4.4 (3.9 to 4.8) | 0 (−0.74 to 0.72) | 0.00 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 49.7 (16.5) | 52.3 (47.6 to 57) | 41 (35.1 to 46.8) | 11.35 (3.24 to 19.37) | 0.84 | |||||
|
|
| 12 weeks | 49.7 (16.5) | 53.3 (48 to 58.8) | 43.9 (37.3 to 50.3) | 9.38 (1.67 to 17.18) | 0.68 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 4.4 (1.1) | 5.1 (4.8 to 5.4) | 4.3 (3.7 to 4.9) | 0.77 (0.17 to 1.37) | 0.81 | |||||
|
|
| 12 weeks | 4.4 (1.1) | 5.1 (4.7 to 5.5) | 4.5 (3.8 to 5.1) | 0.57 (−0.04 to 1.2) | 0.51 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 5.0 (1.3) | 5.3 (4.9 to 5.6) | 4.8 (4.4 to 5.1) | 0.51 (0.14 to 0.92) | 0.70 | |||||
|
|
| 12 weeks | 5.0 (1.3) | 5.2 (4.8 to 5.7) | 5 (4.6 to 5.5) | 0.2 (−0.41 to 0.9) | 0.19 | |||||
|
|
| |||||||||||
|
|
| 6 weeks | 1.6 (1.0) | 2.1 (1.8 to 2.4) | 1.5 (1.2 to 1.9) | 0.56 (0.16 to 0.97) | 0.84 | |||||
|
|
| 12 weeks | 1.6 (1.0) | 2.1 (1.8 to 2.3) | 1.7 (1.3 to 2) | 0.41 (−0.04 to 0.86) | 0.58 | |||||
aCovariates include baseline score for each parameter (as indicated in the pooled mean baseline column), BMI, and sex.
bCIs verified using bias-corrected and accelerated bootstrapping with 5000 repetitions.
cHDL: high-density lipoprotein.
dLDL: low-density lipoprotein.
eCRP: C-reactive protein.
fEQ-5D VAS: EuroQol 5-dimension visual analog scale.
gEQ-5D-5L: EuroQol 5-dimension 5-level questionnaire.
hSF-36: Short Form-36.